Titre:
  • Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years
Auteur:Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE), Rebecca; Lodwick, Dominique; Costagliola, Peter; Reiss, Carlo; Torti, Ramón; Teira, Maria; Dorrucci, Bruno; Ledergerber, Amanda; Mocroft, Daniel; Podzamczer, Alessandro; Cozzi-Lepri, Niels; Obel, Bernard; Masquelier, Schlomo; Staszewski, Federico; Garcia Colominas, Stéphane; De Wit, Antonella; Castagna, Andrea; Antinori, Ali; Judd, Jade; Ghosn, Giota; Touloumi, Cristina; Mussini, Xavier; Duval, José; Ramos, Laurence; Meyer, Josiane; Warsawski, Claire; Thorne, Joan; Masip, Santiago; Pérez-Hoyos, Deenan; Pillay, Ard; van Sighem, Sergio; Lo Caputo, Huldrych; Günthard, Roger; Paredes, Andrea; De Luca, Dimitrios; Paraskevis, Céline; Fabre-Colin, Jesper; Kjaer, Geneviève; Chêne, Jens D; Lundgren, Andrew N.; Phillips,
Informations sur la publication:Archives of internal medicine, 170, 5, page (410-419)
Statut de publication:Publié, 2010-03
Sujet CREF:Sciences bio-médicales et agricoles
Pathologie maladies infectieuses
MeSH keywords:Adolescent
Adult
Anti-HIV Agents -- therapeutic use
Europe
Female
HIV Infections -- drug therapy
HIV Protease Inhibitors -- therapeutic use
Humans
Kaplan-Meier Estimate
Life Expectancy
Male
Middle Aged
Proportional Hazards Models
Reverse Transcriptase Inhibitors -- therapeutic use
Ritonavir -- therapeutic use
Treatment Failure
Viral Load -- drug effects
Young Adult
Langue:Anglais
Identificateurs:urn:issn:0003-9926
info:doi/10.1001/archinternmed.2009.472
info:pii/170/5/410
info:pmid/20212176
PMC3319528